It has been a privilege for the company to participate in the 12th National Bank of Greece Seeds competition and a great honor to receive the first award for our metastasis detection system that provides decision support on the staging of breastcancer, coloncancer, lungcancer as well as melanoma patients. The system is called DeepPath™-LYDIA, received cemarking in May 2022, and is ready to be deployed in hospitals across the UK, Europe and the menaregion. I wish to extend my gratitude to all the organizing committee individuals (especially Spyros Arsenis and Irene Sgourou) as well as all the tutors and evaluators coming for academia, industry and the VC world!
